Order Article Reprints

Silvestri M, Reduzzi C, Feliciello G, Vismara M, Schamberger T, Köstler C, Motta R, Calza S, Ferraris C, Vingiani A, et al. Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients. Cancers. 2021; 13(6):1409. https://doi.org/10.3390/cancers13061409

Silvestri, Marco, Carolina Reduzzi, Giancarlo Feliciello, Marta Vismara, Thomas Schamberger, Cäcilia Köstler, Rosita Motta, Stefano Calza, Cristina Ferraris, Andrea Vingiani, and et al. 2021. "Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients" Cancers 13, no. 6: 1409. https://doi.org/10.3390/cancers13061409

Silvestri, M., Reduzzi, C., Feliciello, G., Vismara, M., Schamberger, T., Köstler, C., Motta, R., Calza, S., Ferraris, C., Vingiani, A., Pruneri, G., Daidone, M. G., Klein, C. A., Polzer, B., & Cappelletti, V. (2021). Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients. Cancers, 13(6), 1409. https://doi.org/10.3390/cancers13061409